The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH-Reference-Cited by-同舟云学术

The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH

Published:2019-07-28 Issue:10 Volume:17 Page:1772-1778
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Wang Tzu‐Fei¹^ORCID,Zwicker Jeffrey I.²^ORCID,Ay Cihan³⁴^ORCID,Pabinger Ingrid³,Falanga Anna⁵⁶,Antic Darko⁷,Noble Simon⁸,Khorana Alok A.⁹,Carrier Marc¹⁰,Meyer Guy¹¹

Affiliation:

1. Division of Hematology Department of Internal Medicine Ohio State University Wexner Medical Center Columbus OH USA

2. Division of Hemostasis and Thrombosis Beth Israel Deaconess Medical Center Harvard Medical School Boston MA USA

3. Clinical Division of Haematology and Haemostaseology Department of Medicine Comprehensive Cancer Center Vienna Medical University of Vienna Vienna Austria

4. I.M. Sechenov First Moscow State Medical University (Sechenov University) Moscow Russia

5. Department of Medicine and Surgery University of Milan Bicocca Milan Italy

6. Department of Immunohematology and Transfusion Medicine Hospital Papa Giovanni XXIII Bergamo Italy

7. Clinic for Hematology Clinical Center Serbia University of Belgrade Belgrade Serbia

8. Marie Curie Palliative Care Research Centre Cardiff University Cardiff Wales UK

9. Taussig Cancer Institute Cleveland Clinic Foundation Cleveland OH USA

10. Department of Medicine Ottawa Hospital Research Institute at the University of Ottawa Ottawa ON Canada

11. Department of Respiratory Disease Hopital Europeen Georges Pompidou AP‐HP INSERM CIC1418 Université Paris Descartes Sorbonne Paris Cité Paris France

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14564

Reference19 articles.

1. Prevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTH

2. Epidemiology of cancer-associated venous thrombosis

3. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

4. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy;Nisio M;Cochrane Database Syst Rev,2016

5. An individual participant data meta‐analysis of 13 randomized trials to evaluate the impact of prophylactic use of heparin in oncological patients;Schunemann H;Blood,2017

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venous thromboembolism prevention program implementation in a community oncology practice: a cohort study;The Lancet Regional Health - Americas;2024-10

2. Preventative and curative treatment of venous thromboembolic disease in cancer patients;La Presse Médicale;2024-09

3. Venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer;International Journal of Gynecologic Cancer;2024-08-24

4. Venous Thromboembolism in Patients with Glioblastoma: Molecular Mechanisms and Clinical Implications;Thrombosis and Haemostasis;2024-08-21

5. Venous Thromboembolism Prevention in Rehabilitation;American Journal of Physical Medicine & Rehabilitation;2024-06-21